Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of acyline and testosterone is a hormonal regimen that has been studied primarily for male contraception and other endocrine-related conditions. Acyline is a GnRH antagonist that suppresses gonadotropin and testosterone production, while testosterone is administered to maintain normal hormonal function while suppressing spermatogenesis. ## Mechanism of Action Acyline works by blocking the gonadotropin-releasing hormone receptor (GnRHR), which leads to suppression of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland[2]. This results in decreased endogenous testosterone production. The exogenous testosterone is then administered to maintain normal serum testosterone levels while still suppressing spermatogenesis through negative feedback mechanisms[1][4]. Studies have shown that this combination significantly reduces intratesticular testosterone levels (to 1.9-2.6% of control levels) and suppresses germ cell development from type B spermatogonia onward[1]. The combination effectively creates a hormonal environment that inhibits sperm production while maintaining normal systemic testosterone levels. ## Clinical Studies Research has investigated various formulations of this combination: - Testosterone enanthate (TE) injections (100 mg weekly) combined with acyline (300 μg/kg twice weekly subcutaneously)[1] - Testosterone gel (Testim) with acyline[7] The combination has been studied for: - Male contraception (reaching Phase 3 trials)[6] - Androgen deficiency (Phase 2)[6] - Type 2 diabetes mellitus (Phase 2)[6] - Insulin resistance (Phase 2)[6] - Obesity (Phase 2)[6] ## Administration Acyline is typically administered via subcutaneous injection, while testosterone can be administered through various routes including intramuscular injection (testosterone enanthate) or topical application (testosterone gel)[1][7]. The combination creates a potent suppression of spermatogenesis and intratesticular steroids, making it potentially effective for hormonal male contraception and treatment of hormone-dependent conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acyline + testosterone.